Pre-eclampsia, the placenta and the maternal systemic inflammatory response - A review

Placenta

Volumn 24, Issue SUPPL. A, 2003, Pages

  Redman, Christopher W G ^a   Sargent, I L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

APOPTOSIS; CLINICAL OBSERVATION; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; PATHOGENESIS; PLACENTA; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; SYNCYTIOTROPHOBLAST; THIRD TRIMESTER PREGNANCY;

EID: 0141838133     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2002.0930     Document Type: Article

References (68)

1. Aardema MW, Oosterhof H, Timmer A, van-Rooy I & Aarnoudse JG (2001) Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses. Placenta, 22, 405-411.
2. Arkwright PD, Rademacher TW, Dwek RA & Redman CWG (1993) Pre-eclampsia is associated with an increase in trophoblast glycogen content and glycogen synthase activity, similar to that found in hydatidiform moles. J Clin Invest, 91, 2744-2753.
3. Aupeix K, Hugel B, Martin T, Bischoff P, Lill H, Pasquali JL & Freyssinet JM (1997) The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest, 99, 1546-1554.
4. Benyo DF, Smarason A, Redman CWG, Sims C & Conrad KP (2001) Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab, 86, 2505-2512.
5. Brosens I & Renaer M (1972) On the pathogenesis of placental infarcts in pre-eclampsia. J Obstet Gynaecol Br Commonw, 79, 779-794.
6. Cester N, Staffolani R, Rabini RA, Magnanelli R, Salvolini E, Galassi R, Mazzanti L & Romanini C (1994) Pregnancy induced hypertension, a role for peroxidation in microvillus plasma membranes. Mol Cell Biochem, 131, 151-155.
7. Chabloz P, Reber G, Boehlen F, Hohlfeld P & de-Moerloose P (2001) TAFI antigen and D-dimer levels during normal pregnancy and at delivery. Br J Haematol, 115, 150-152.
8. Conrad KP, Miles TM & Benyo DF (1998) Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol, 40, 102-111.
9. Eichinger S, Weltermann A, Philipp K, Hafner E, Kaider A, Kittl EM, Brenner B, Mannhalter C, Lechner K & Kyrle PA (1999) Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemostas, 82, 1232-1236.
10. Ellis J, Wennerholm UB, Bengtsson A, Lilja H, Pettersson A, Sultan B, Wennergren M & Hagberg H (2001) Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand, 80, 602-608.
11. Esmon CT, Fukudome K, Mather T, Bode W, Regan LM, Stearns-Kurosawa DJ & Kurosawa S (1999) Inflammation, sepsis, and coagulation. Haematologica, 84, 254-259.
12. Gratacos E, Casals E, Deulofeu R, Cararach V, Alonso PL & Fortuny A (1998) Lipid peroxide and vitamin E patterns in pregnant women with different types of hypertension in pregnancy. Am J Obstet Gynecol, 178, 1072-1076.
13. Greer IA, Lyall F, Perera T, Boswell F & Macara LM (1994) Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia, a mechanism for endothelial dysfunction? Obstet Gynecol, 84, 937-940.
14. Haeger M, Bengtson A, Karlsson K & Heideman M (1989) Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid. Obstet Gynecol, 73, 551-556.
15. Haig D (1993) Genetic conflicts in human pregnancy. Q Rev Biol, 68, 495-532.
16. Hanna N, Hanna I, Hleb M, Wagner E, Dougherty J, Balkundi D, Padbury J & Sharma S (2000) Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J Immunol, 164, 5721-5728.
17. Hensley K, Robinson KA, Gabbita SP, Salsman S & Floyd RA (2000) Reactive oxygen species, cell signaling, and cell injury. Free Radical Biol Med, 28, 1456-1462.
18. Heyl W, Handt S, Reister F, Gehlen J, Schroder W, Mittermayer C & Rath W (1999) Elevated soluble adhesion molecules in women with pre-eclampsia. Do cytokines like tumour necrosis factor-alpha and interleukin-1beta cause endothelial activation. Eur J Obstet Gynecol Reprod Biol, 86, 35-41.
19. Holland E (1909) Recent work on the aetiology of eclampsia. J Obstet Gynaecol Br Emp, 16, 255-273.
20. Hopkinson ND & Powell RJ (1992) Classical complement activation induced by pregnancy, implications for management of connective tissue diseases. J Clin Pathol, 45, 66-67.
21. Hubel CA (1998) Dyslipidemia, iron, and oxidative stress in preeclampsia, assessment of maternal and feto-placental interactions. Semin Reprod Endocrinol, 16, 75-92.
22. Huppertz B, Frank HG, Kingdom JC, Reister F & Kaufmann P (1998) Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol, 110, 495-508.
23. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T & Maruo T (2002) Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol, 186, 158-166.
24. Janes SL & Goodall AH (1994) Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. Clin Sci Colch, 86, 731-739.
25. Johansen M, Redman CWG, Wilkins T & Sargent IL (1999) Trophoblast deportation in human pregnancy-its relevance for pre-eclampsia. Placenta, 20, 531-539.
26. Jones CJ & Fox H (1980) An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta, 1, 61-76.
27. Kaar K, Jouppila P, Kuikka J, Luotala H, Toivanen J & Rekonen A (1980) Intervillous blood flow in normal and complicated late pregnancy measured by means of an intravenous 133Xe method. Acta Obstet Gynecol Scand, 59, 7-10.
28. King A, Hiby SE, Gardner L, Joseph S, Bowen JM, Verma S, Burrows TD & Loke YW (2000) Recognition of trophoblast HLA class I molecules by decidual NK cell receptors - a review. Placenta, 21(Suppl A), S81-S85.
29. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW & Hotamisligil GS (1997) Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest, 100, 2777-2782.
30. Kirwan JP, Hauguel-De-Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC & Catalano PM (2002) TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes, 51, 2207-2213.
31. Knight M, Redman CWG, Linton EA & Sargent IL (1998) Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol, 105, 632-640.
32. Konijnenberg A, Stokkers EW, van-der PJ, Schaap MC, Boer K, Bleker OP & Sturk A (1997) Extensive platelet activation in preeclampsia compared with normal pregnancy, enhanced expression of cell adhesion molecules. Am J Obstet Gynecol, 176, 461-469.
33. Levy R, Smith SD, Chandler K, Sadovsky Y & Nelson DM (2000) Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell Physiol, 278, C982-C988.
34. Li N & Karin M (1999) Is NF-kappaB the sensor of oxidative stress? FASEB J, 13, 1137-1143.
35. Li DK & Wi S (2000) Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. Am J Epidemiol, 151, 57-62.
36. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie NE & Irgens LMF (1998) Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ, 316, 1343-1347.
37. Little WA (1960) Placental infarction. Obstet Gynecol, 15, 109-130.
38. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, Haines CJ & Redman CWG (1999) Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem, 45, 184-188.
39. Lusis AJ (2000) Atherosclerosis. Nature, 407, 233-241.
40. Mayhew TM, Leach L, McGee R, Ismail WW, Myklebust R & Lammiman MJ (1999) Proliferation, differentiation and apoptosis in villous trophoblast at 13-41 weeks of gestation (including observations on annulate lamellae and nuclear pore complexes). Placenta, 20, 407-422.
41. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR & van Assche (1994) A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol, 101, 669-674.
42. Mellembakken JR, Aukrust P, Olafsen MK, Ueland T, Hestdal K & Videm V (2002) Activation of leukocytes during the uteroplacental passage in preeclampsia. Hypertension, 39, 155-160.
43. Mires GJ, Williams FL, Leslie J & Howie PW (1998) Assessment of uterine arterial notching as a screening test for adverse pregnancy outcome. Am J Obstet Gynecol, 179, 1317-1323.
44. Morris JM, Gopaul NK, Endresen MJ, Knight M, Linton EA, Dhir S, Anggard EE & Redman CWG (1998) Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol, 105, 1195-1199.
45. Nelson DM (1996) Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta, 17, 387-391.
46. Ness RB & Roberts JM (1996) Heterogeneous causes constituting the single syndrome of preeclampsia, a hypothesis and its implications. Am J Obstet Gynecol, 175, 1365-1370.
47. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L & van Assche A (1991) Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol, 98, 648-655.
48. Pollak VE & Nettles JB (1960) The kidney in toxemia of pregnancy, a clinical and pathologic study based on renal biopsies. Medicine, 39, 469-526.
49. Redman CWG (1991) Current topic. Pre-eclampsia and the placenta. Placenta, 12, 301-308.
50. Redman CWG (1992) The placenta and pre-eclampsia. In The Human Placenta (Eds) Redman CWG, Sargent IL & Starkey PM, pp. 433-467. Oxford: Blackwell Scientific Publications.
51. Redman CWG, Sacks GP & Sargent IL (1999) Preeclampsia, an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol, 180, 499-506.
52. Redman CWG & Sargent IL (2000) Placental debris, oxidative stress and pre-eclampsia. Placenta, 21, 597-602.
53. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA & McLaughlin MK (1989) Preeclampsia, an endothelial cell disorder. Am J Obstet Gynecol, 161, 1200-1204.
54. Robertson WB, Brosens I & Dixon G (1976) Maternal uterine vascular lesions in the hypertensive complications of pregnancy. Perspect Nephrol Hypertens, 5, 115-127.
55. Robertson WB, Brosens I & Landells WN (1985) Abnormal placentation. Obstet Gynecol Annual, 14, 411-426.
56. Sacks GP, Studena K, Sargent K & Redman CWG (1998) Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol, 179, 80-86.
57. Salafia CM, Pezzullo JC, Ghidini A, Lopez-Zeno JA, Whittington SS (1998) Clinical correlations of patterns of placental pathology in preterm pre-eclampsia. Placenta, 19, 67-72.
58. Schrocksnadel H, Daxenbichler G, Artner E, Steckel Berger G & Dapunt O (1993) Tumor markers in hypertensive disorders of pregnancy. Gynecol Invest, 35, 204-208.
59. Shanklin DR & Sibai BM (1989) Ultrastructural aspects of pre-eclampsia. 1. Placental bed and uterine boundary vessels. Am J Obstet Gynecol, 161, 735-741.
60. Shibata E, Ejima K, Nanri H, Toki N, Koyama C, Ikeda M & Kashimura M (2001) Enhanced protein levels of protein thiol/disulphide oxidoreductases in placentae from pre-eclamptic subjects. Placenta, 22, 566-572.
61. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM & Friedman SA (1993) Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol, 169, 1000-1006.
62. Smarason AK, Sargent IL, Starkey PM & Redman CWG (1993) The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol, 100, 943-949.
63. Strevens H, Wide-Swensson D, Hansen A, Horn T, Ingemarsson I, Larsen S, Willner J & Olsen S (2002) Glomerular endotheliosis found in antepartum renal biopsies in both normal and hypertensive pregnancies. BJOG (In press).
64. Tanaka T, Itoh H, Doi K, Fukunaga Y, Hosoda K, Shintani M, Yamashita J, Chun TH, Inoue M, Masatsugu K, Sawada N, Saito T, Inoue G, Nishimura H, Yoshimasa Y & Nakao K (1999) Down regulation of peroxisome proliferator-activated receptorgamma expression by inflammatory cytokines and its reversal by thiazolidinediones. Diabetologia, 42, 702-710.
65. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D & Redman CWG (1995) Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol, 102, 20-25.
66. Wang JH, Redmond HP, Watson RW, Duggan S, McCarthy J, Barry M & Bouchier Hayes D (1996) Mechanisms involved in the induction of human endothelial cell necrosis. Cell Immunol, 168, 91-99.
67. Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, O'Reilly GC, King IB, Zebelman AM & Luthy DA (1999) Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol, 149, 323-329.
68. Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Sibai BM, Holzgreve W & Hahn S (2001) Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol, 184, 414-419.